A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 39/145 (2006.01) A61K 47/00 (2006.01) A61K 47/02 (2006.01) A61K 47/10 (2006.01) A61K 47/12 (2006.01) A61K 47/18 (2006.01) A61K 47/20 (2006.01)
Patent
CA 2252565
This invention relates to novel methods and formulations of nucleic acid pharmaceutical products, specifically formulations of nucleic acid vaccine products and nucleic acid gene therapy products. The formulations of the disclosure stabilize the conformation of DNA pharmaceutical products.
L'invention concerne de nouvelles méthodes et des formulations de produits pharmaceutiques à base d'acides nucléiques, notamment des formulations de produits de vaccination à base d'acides nucléiques et de produits de thérapie génique à base d'acides nucléiques. Les formulations de la présente invention permettent de stabiliser la conformation des produits pharmaceutiques à ADN.
Bruner Mark
Evans Robert K.
Volkin David B.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Dna vaccine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dna vaccine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna vaccine formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549317